Literature DB >> 18322382

Preamyloid lesions and cerebrovascular deposits in the mechanism of dementia: lessons from non-beta-amyloid cerebral amyloidosis.

Agueda Rostagno1, Jorge Ghiso.   

Abstract

The importance of amyloid plaques in the pathogenesis of dementia is usually centered on beta-amyloid (Abeta) and its role in Alzheimer's disease (AD). However, since fibrillar plaques correlate poorly with neurodegeneration, challenging their importance in the mechanism(s) of dementia, investigators turned their focus to the importance of soluble oligomers and the role of preamyloid and cerebrovascular deposits. Two non-Abeta cerebral amyloidoses, familial British and Danish dementias (FBD and FDD), share many aspects of AD, including cognitive impairment and the presence of neurofibrillary tangles in limbic areas. The lack of compact plaques in FDD and in many areas in FBD further questions the importance of these lesions in the mechanism of dementia. The main components of the deposits--ABri and ADan--are structurally unrelated to Abeta and yet they all have a high tendency to oligomerize and assemble into amyloid fibrils in vitro and form ion-like channels in lipid membranes. Thus, different amyloid species have the capability to induce similar neuropathological changes, which are neither exclusive for Abeta nor dependent on the presence of compact plaques. These findings reaffirm the notion that non-Abeta amyloidoses constitute alternative models to study the role of preassembled amyloid subunits in neuronal death. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322382      PMCID: PMC2826450          DOI: 10.1159/000113694

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  12 in total

Review 1.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

2.  Amyloid ion channels: a common structural link for protein-misfolding disease.

Authors:  Arjan Quist; Ivo Doudevski; Hai Lin; Rushana Azimova; Douglas Ng; Blas Frangione; Bruce Kagan; Jorge Ghiso; Ratnesh Lal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

Review 3.  Chromosome 13 dementias.

Authors:  A Rostagno; Y Tomidokoro; T Lashley; D Ng; G Plant; J Holton; B Frangione; T Revesz; J Ghiso
Journal:  Cell Mol Life Sci       Date:  2005-08       Impact factor: 9.261

4.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

5.  A stop-codon mutation in the BRI gene associated with familial British dementia.

Authors:  R Vidal; B Frangione; A Rostagno; S Mead; T Révész; G Plant; J Ghiso
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

6.  A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.

Authors:  R Vidal; T Revesz; A Rostagno; E Kim; J L Holton; T Bek; M Bojsen-Møller; H Braendgaard; G Plant; J Ghiso; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

7.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Authors: 
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

Review 8.  Amyloidosis and Alzheimer's disease.

Authors:  Jorge Ghiso; Blas Frangione
Journal:  Adv Drug Deliv Rev       Date:  2002-12-07       Impact factor: 15.470

9.  Genetic alterations of the BRI2 gene: familial British and Danish dementias.

Authors:  J Ghiso; A Rostagno; Y Tomidokoro; T Lashley; M Bojsen-Møller; H Braendgaard; G Plant; J Holton; R Lal; T Revesz; B Frangione
Journal:  Brain Pathol       Date:  2006-01       Impact factor: 6.508

10.  Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal.

Authors:  John Hardy
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

View more
  5 in total

1.  Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells.

Authors:  Mar Hernandez-Guillamon; Stephanie Mawhirt; Silvia Fossati; Steven Blais; Mireia Pares; Anna Penalba; Merce Boada; Pierre-Olivier Couraud; Thomas A Neubert; Joan Montaner; Jorge Ghiso; Agueda Rostagno
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

2.  Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study.

Authors:  Nilay S Shah; Jean-Sébastien Vidal; Kamal Masaki; Helen Petrovitch; G Webster Ross; Cathy Tilley; Ronald B DeMattos; Russell P Tracy; Lon R White; Lenore J Launer
Journal:  Hypertension       Date:  2012-03-05       Impact factor: 10.190

3.  Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits.

Authors:  Yasushi Tomidokoro; Agueda Rostagno; Thomas A Neubert; Yun Lu; G William Rebeck; Blas Frangione; Steven M Greenberg; Jorge Ghiso
Journal:  Am J Pathol       Date:  2010-03-12       Impact factor: 4.307

4.  A new mechanism links preamyloid oligomer formation in the myocyte stress response associated with atrial fibrillation.

Authors:  Jason Pellman; Farah Sheikh
Journal:  J Mol Cell Cardiol       Date:  2014-12-23       Impact factor: 5.000

5.  Characterization of Amyloid-β Deposits in Bovine Brains.

Authors:  Elena Vallino Costassa; Michele Fiorini; Gianluigi Zanusso; Simone Peletto; Pierluigi Acutis; Elisa Baioni; Cristiana Maurella; Fabrizio Tagliavini; Marcella Catania; Marina Gallo; Monica Lo Faro; Maria Novella Chieppa; Daniela Meloni; Antonio D'Angelo; Orlando Paciello; Roberta Ghidoni; Elisa Tonoli; Cristina Casalone; Cristiano Corona
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.